Overview
Status
Active
Registry date
2013-05-17
Share capital
5,000.00 PLN
Registered address
Wronia 45/U2, 00-870 Warszawa, Poland
Electronic delivery address
AE:PL-63882-24000-IWSFI-34
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 94 days for 2021).
- 2025filed
- 202414/07/2025
- 202312/07/2024
- 202217/07/2023
- 202117/10/2022
- 202015/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Ireneusz Włodzimierz Szczęsny – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Małgorzata Szczęsnaage 61 | 50 | $675.31 | 50% |
Ireneusz Włodzimierz Szczęsnyage 62 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
4 closed proceedings recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Dec 16, 2022 | Discontinued enforcement proceedings | Closed | |
| Dec 16, 2022 | Discontinued enforcement proceedings | Closed | |
| Dec 16, 2022 | Discontinued enforcement proceedings | Closed | |
| Dec 16, 2022 | Discontinued enforcement proceedings | Closed |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-08-29 | Address change (Ul. Żelazna 67/13, 00-871, Warszawa → Wronia 45/U2, 00-870, Warszawa) | |
| 2016-04-20 | Address change (Prosta 32, 00-838, Warszawa → Ul. Żelazna 67/13, 00-871, Warszawa) | |
| 2016-04-20 | PKD change (Removed: 49 codes; Added: 1 code) | |
| 2013-05-17 | Entered in the register |
FAQ
The main business activity of Victoria-Invest focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on May 17, 2013.
The headquarters is located at: Wronia 45, 00-870 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-04-26
